D2R Bioinformatics Llp - Due diligence report

A 360° intelligence report on D2R Bioinformatics Llp: trust score, financial health, credit view, compliance, directors, growth and distress…

2020-07-16 Hyderabad, Telangana Strike Off
Share
Connect MCP
DB D2R Bioinformatics Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

D2R Bioinformatics Llp — 360° Intelligence Report

Generated from MCA filings & public records
57/100
Trust Score
Moderate

D2R Bioinformatics Llp is assessed as Moderate with a Trust Score of 57/100. D2R Bioinformatics Llp is a limited liability partnership incorporated in 2020, operating in the Research & Development sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. D2R Bioinformatics Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
57/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2024 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
DEVAKIAMMA SWAYAM PRABHA NAIR 01234567 Director 01/04/2018 6 yrs Approved
MAHESH SWAYAM KUMUD 01234567 Director 01/04/2018 6 yrs Approved
MAHESH KIRON SWAYAM 01234567 Director 01/04/2018 6 yrs Approved
VAITHEESWARAN VEMBU KOLADY 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 6 years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence46/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment47/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view37/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Mar 2024
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
16 Jul 2020
Incorporated
Registered with Roc Hyderabad
Director appointed
DEVAKIAMMA SWAYAM PRABHA NAIR (Designated Partner)
Director appointed
MAHESH SWAYAM KUMUD (Designated Partner)
Director appointed
MAHESH KIRON SWAYAM (Partner)
Director appointed
VAITHEESWARAN VEMBU KOLADY (Partner)
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
SUDHA THERAPEUTICS PRIVATE LIMITED U24232TG2008PTC059019 Hyderabad, Telangana
Incredible Financial Services Private Limited U67190TG2008PTC056960 Hyderabad, Telangana
SHIVA KESHAV INDUSTRIES LLP ACA-3092 Hyderabad, Telangana
Callidus Systems Private Limited U72900TG2003PTC040401 Hyderabad, Telangana
Dano Vaccines And Biologicals Pvt Ltd U24231TG1984PTC005135 Hyderabad, Telangana
Pahilvan'S Enterprises Private Limited U52390TG2012PTC080197 Hyderabad, Telangana
Axes India Private Limited U70100TG2012PTC083903 Hyderabad, Telangana
Sumptuous It Solutions & Services Private Limited U72900TG2017PTC114202 Hyderabad, Telangana
MAANYA HOLDINGS LLP AAM-6343 Hyderabad, Telangana
RAGHAVEE BEWERAGES PRIVATE LIMITED U15500TG2008PTC059347 Hyderabad, Telangana
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify D2R Bioinformatics Llp before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of D2R Bioinformatics Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for D2R Bioinformatics Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 57/100, distress signals and MSME payment-delay disclosures - know whether D2R Bioinformatics Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for D2R Bioinformatics Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is D2R Bioinformatics Llp an active company?

D2R Bioinformatics Llp has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is D2R Bioinformatics Llp financially healthy?

Processed financial statements are not yet available for D2R Bioinformatics Llp, so its financial health is unassessed.

Should I do business with D2R Bioinformatics Llp?

Its overall Trust Score is 57/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls D2R Bioinformatics Llp?

See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.

Does D2R Bioinformatics Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is D2R Bioinformatics Llp up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to D2R Bioinformatics Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.